Biograph completes first U.S. study with Caristo Diagnostics’ AI-Powered Coronary Inflammation Detection, finding risk in over 42% of asymptomatic patients - Biograph Preventive Health & Longevity
- Biograph, the world’s most advanced preventive health and diagnostics clinic, today announced the completion of its first U.
- study using Caristo Diagnostics’ CaRi-Heart® technology evaluating AI-powered coronary inflammation detection in asymptomatic, low-risk individuals.
- The research revealed that coronary inflammation is widespread among asymptomatic adults without known heart disease – and is undetected by standard blood tests and other traditional cardiovascular risk factors.
Unverified
- Biograph, the world’s most advanced preventive health and diagnostics clinic, today announced the completion of its first U.
- study using Caristo Diagnostics’ CaRi-Heart® technology evaluating AI-powered coronary inflammation detection in asymptomatic, low-risk individuals.
- The research revealed that coronary inflammation is widespread among asymptomatic adults without known heart disease – and is undetected by standard blood tests and other traditional cardiovascular risk factors.
Sources: Biograph